6-12F (15F max outer diameter) Venous Closure
FDA Approved FDA Approved

Proven

Proven by EPs in the ambulate pivotal trial

 

VASCADE MVP was evaluated in the AMBULATE pivotal trial. AMBULATE was a multicenter, randomized clinical trial with 204 patients randomized 1:1 to VASCADE MVP or manual compression.

Read the full JACC EP published articleJust Published

Opioid Use1

Number of Patients Receiving Opioids Post-Procedure

Manual Comp = 37 pts
VASCADE MVP = 15 pts

Patient Satisfaction with Duration of Bedrest

Comparison to Bedrest from a Previous Cardiac Ablation Procedure

Manual Comp = 5.6 vs.
VASCADE MVP = 7.9 mean

All Patients

Manual Comp = 5.1 vs.
VASCADE MVP = 8.3 mean

1 As demonstrated in the AMBULATE Pivotal Trial. | * Cardiac ablations requiring two or more access sites within the same limb. See VASCADE MVP IFU 3972 Indications for Use

VASCADE MVP® Videos and Literature

VASCADE MVP® Procedure
VASCADE MVP® Procedure - Multi Vessel Closure Following AF Ablation Dr Rodney Horton
VASCADE MVP® Procedure - Multi Vessel Closure Following Cardiac Cryoablation Dr Suneet Mittal
VASCADE MVP® Procedure - WATCHMAN Access Site Closure Dr Suneet Mittal
Benefits of VASCADE MVP®: Patient, Physician and Nurse Perspectives

Call us today
Toll Free: (in the U.S.)
1-866-602-6099


Need to speak
with a Cardiva
Representative?

Request a Call

Directions
1615 Wyatt Drive
Santa Clara, CA 95054